Search all medical codes
Immunoassay for analyte other than infectious agent antibody or infectious agent antigen; qualitative or semiquantitative, multiple step method
CPT4 code
Name of the Procedure:
Immunoassay for Analyte (Qualitative or Semiquantitative, Multiple Step Method)
- Common names: Immunoassay, Non-Infectious Analyte Immunoassay
- Technical terms: Multiple Step Immunoassay, Non-Infectious Agent Analyte Testing
Summary
This type of immunoassay is a laboratory test used to detect the presence or amount of a specific substance (analyte) in a sample through a series of steps that indicates a qualitative (presence/absence) or semiquantitative (approximate amount) result.
Purpose
- To detect and measure a specific analyte in the body that is not associated with infectious agents.
- Commonly used to test for hormones, drugs, proteins, and other chemicals in the blood or urine.
- The goal is to diagnose and monitor various medical conditions or to ensure therapeutic drug levels are within the desired range.
Indications
- Symptoms or suspicion of hormonal imbalances, drug toxicity, or metabolic disorders.
- Monitoring therapeutic drug levels in patients on medication.
- Screening for specific proteins or biomarkers in research or clinical settings.
Preparation
- Some tests may require fasting, typically for 8-12 hours before sample collection.
- Patients should inform the healthcare provider of all medications, supplements, and underlying health conditions.
- Routine diagnostics like blood or urine samples may be collected.
Procedure Description
- Sample Collection: Blood is drawn from a vein or a urine sample is collected.
- Preparation: The sample is prepared and treated with specific reagents that bind to the target analyte.
- Binding: The sample and reagents undergo multiple binding stages wherein a series of reactions occur.
- Detection: The final reaction often involves a detectable signal, such as color change, fluorescence, or radioactivity, indicating the presence or quantity of the analyte.
- Tools/Technology: Microplate readers, spectrophotometers, fluorimeters, or radioimmunoassay counters.
- Anesthesia/Sedation: Not required.
Duration
- Typically takes between 1 to 3 hours for the full process, including sample processing and analysis.
Setting
- Performed in a clinical laboratory or hospital laboratory setting.
Personnel
- Laboratory technicians or technologists.
- Pathologists may interpret the results.
Risks and Complications
- Minimal risk from blood draw: slight bruising, soreness, or very rarely, infection.
- Incorrect results due to sample contamination or improper handling.
Benefits
- Provides critical information for diagnosis and treatment management.
- Results typically available same day or within a few days.
- Non-invasive with minimal discomfort.
Recovery
- No recovery time is needed; patients can immediately resume normal activities post-sample collection.
- Follow-up with healthcare provider to discuss result interpretation and next steps.
Alternatives
- Other testing methods like mass spectrometry or chromatography.
- Pros: These may provide more detailed quantitative data.
- Cons: Often more expensive and time-consuming, requiring specialized equipment and personnel.
Patient Experience
- During: Brief discomfort during blood draw; otherwise no pain or discomfort.
- After: Minimal to no side effects; routine care for the blood draw site as recommended in everyday blood collection such as applying a bandage.